Buy Rating Affirmed for Gain Therapeutics on Promising GT-02287 Clinical Progress
TipRanksApr 25 12:15 ET
Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), Acrivon Therapeutics, Inc. (ACRV) and Gain Therapeutics (GANX)
TipRanksApr 25 06:30 ET
Gain Therapeutics Analyst Ratings
BenzingaApr 25 06:36 ET
Gain Therapeutics Analyst Ratings
BenzingaApr 23 08:20 ET
Oppenheimer Remains a Buy on Gain Therapeutics (GANX)
TipRanksApr 23 07:45 ET
Gain Therapeutics Analyst Ratings
BenzingaApr 1 07:14 ET
Optimistic Buy Rating for Gain Therapeutics Backed by Strong Financials and Promising Parkinson's Drug Candidate GT-02287
TipRanksMar 27 13:25 ET
Chardan Capital Reiterates Buy on Gain Therapeutics, Maintains $6 Price Target
BenzingaMar 27 04:38 ET
Gain Therapeutics Analyst Ratings
BenzingaMar 27 04:36 ET
Buy Rating for Gain Therapeutics Backed by Strong Preclinical Data and Promising Parkinson's Candidate GT-02287
TipRanksFeb 7 06:16 ET
Buy Rating Affirmed: Gain Therapeutics' Promising GT-02287 Advances Towards Key Clinical Milestones in Parkinson's Disease Treatment
TipRanksFeb 1 15:35 ET
Analysts Offer Insights on Healthcare Companies: Gain Therapeutics (GANX), Humana (HUM) and Boston Scientific (BSX)
TipRanksFeb 1 06:50 ET
Gain Therapeutics (GANX) Gets a Buy From BTIG
TipRanksJan 7 05:34 ET
Buy Rating Affirmed: Gain Therapeutics' GT-02287 Shows Promise in Parkinson's Disease Pipeline
TipRanksJan 3 12:45 ET
HC Wainwright & Co. Maintains Buy on Gain Therapeutics, Lowers Price Target to $9
BenzingaDec 4, 2023 06:47 ET
Gain Therapeutics Analyst Ratings
BenzingaDec 4, 2023 06:46 ET
Buy Rating on Gain Therapeutics Backed by Promising Parkinson's Candidate GT-02287 and Strengthened Financial Position
TipRanksDec 4, 2023 06:17 ET
Promising Clinical Trials and Financial Outlook Boost Gain Therapeutics: A Comprehensive Buy Rating Analysis
TipRanksNov 17, 2023 06:27 ET
Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN) and Gain Therapeutics (GANX)
TipRanksNov 15, 2023 12:10 ET
Promising Therapeutic Approaches and Financial Stability Bolster Buy Rating for Gain Therapeutics
TipRanksNov 15, 2023 06:22 ET
No Data
No Data